Author(s)

Tabitha Mok, Jo Crittenden, Brendan McQuillan, Sean Hood

School of Psychiatry and Clinical Neurosciences, The University of Western Australia, Perth, Australia.

Objective: In this pilot study, given the prevalence of hypertension and panic disorder as described in the literature, we proposed to fill the gaps in the literature on the possible utility of SSRI medication as an adjunct treatment in individuals with panic disorder and hypertension. Methods: We planned to only recruit patients with panic disorder who fit the criteria independently for treatment with SSRI; i.e. treatment would be given based on clinical need and currently accepted Pharmaceutical Benefits Scheme (PBS) criteria. Thereafter, we would monitor their BP at baseline, 14 days and 28 days to determine if there has been an effect on the individual’s BP. Results: Based on the observation above, there may be a trend of a reduction in systolic and diastolic BP after the commencement of sertraline. Conclusion: In order to confirm this observation, a larger sample size is required in the future. This pilot study proposed to meet the objectives as listed below; however due to difficulty with recruitment, only 2 out of 4 participants will be discussed in the analysis.

Panic Disorder, Hypertension, SSRI, Cardiology

Mok, T. , Crittenden, J. , McQuillan, B. and Hood, S. (2019) The Effects of Low Dose Sertraline on Blood Pressure in Patients with Hypertension and Panic Disorder: A Pilot Study. Open Journal of Psychiatry, 9, 249-266. doi: 10.4236/ojpsych.2019.94019.